86 FR 237 pg. 71068 - Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID)
Type: NOTICEVolume: 86Number: 237Page: 71068
Page: 71068FR document: [FR Doc. 2021-26954 Filed 12-13-21; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID)
AGENCY:
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice of meeting.
SUMMARY:
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID). This virtual meeting is open to the public via Zoom, limited only by the space available, which is 500 seats. Pre-registration is required by accessing the link below in the addresses section.
DATES:
The meeting will be held on January 19-20, 2022, from 1:00 p.m. to 5:30 p.m., EST.
ADDRESSES:
Zoom virtual meeting. Pre-registration is required by accessing the link at https://cdc.zoomgov.com/webinar/register/WN_vXuOtDbNQIycPMScOPKvKQ. Instructions to access the meeting will be provided following registration.
FOR FURTHER INFORMATION CONTACT:
Hilary Eiring, MPH, Designated Federal Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia 30329-4027, Telephone: (770) 488-3901; Email: HEiring@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director and the Deputy Director for Infectious Diseases (DDID), CDC; and the Directors of the National Center for Emerging and Zoonotic Infectious Diseases, the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, and the National Center for Immunization and Respiratory Diseases, CDC, in the following areas: Strategies, goals, and priorities for programs and research within the national centers and monitor the overall strategic direction and focus of DDID and the national centers.
Matters To Be Considered: The agenda will include updates and discussions on recent outbreaks; updates and discussions on CDC's Center for Forecasting and Outbreak Analytics, advanced molecular detection program, Data Modernization Initiative, and CORE Health Equity Science and Intervention Strategy; and other updates and reports, including a brief report back from the Board's Food Safety Modernization Act Surveillance Working Group. Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-26954 Filed 12-13-21; 8:45 am]
BILLING CODE 4163-18-P